Trials / Completed
CompletedNCT00358345
PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization
PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 347 (actual)
- Sponsor
- Notal Vision Ltd. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to assess the ability of the PreView PHP(study device)to detect newly diagnosed non-treated Choroidal Neovascularization (CNV)lesion associate with advanced Age-related Macular Degeneration (AMD) or Myopia and differentiate them from Intermediate AMD or Geographic Atrophy (GA)or patients with high Myopia with no CNV. This study secondary is to enhance NotalVision normative database.
Detailed description
* The study is prospective, multi-center, comparative study. * A clinical trail with FDA approval device (510K).
Conditions
Timeline
- Start date
- 2003-10-01
- Completion
- 2007-09-01
- First posted
- 2006-07-31
- Last updated
- 2008-01-15
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00358345. Inclusion in this directory is not an endorsement.